Antengene
Antengene Corporation Limited, headquartered in China, is a pioneering biopharmaceutical company focused on the development and commercialisation of innovative therapies for cancer treatment. Founded in 2017, Antengene has rapidly established itself in the oncology sector, with a strong emphasis on precision medicine and targeted therapies. The company operates primarily in Asia-Pacific regions, aiming to address unmet medical needs through its robust pipeline of novel drug candidates. Antengene's core products include a range of innovative therapies that leverage cutting-edge technology, setting them apart in a competitive market. With notable achievements in clinical trials and strategic partnerships, Antengene is positioned as a key player in the biopharmaceutical industry, committed to improving patient outcomes and advancing cancer care globally.
DitchCarbon Score
How does Antengene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Antengene's score of 25 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Antengene's reported carbon emissions
In 2023, Antengene Corporation Limited reported total carbon emissions of approximately 1,169,980 kg CO2e. This figure includes about 45,220 kg CO2e from Scope 1 emissions and approximately 1,124,760 kg CO2e from Scope 2 emissions. The company has shown a reduction in total emissions from 2022, where emissions were about 1,613,260 kg CO2e, comprising around 551,320 kg CO2e in Scope 1 and approximately 1,061,940 kg CO2e in Scope 2. Antengene has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. The company has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, which suggests that while emissions data is available, formal commitments to reduction strategies are currently lacking. Overall, Antengene's emissions data reflects a commitment to transparency, but the absence of reduction targets highlights an opportunity for the company to enhance its climate strategy and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 27,080 | 00,000 | 000,000 | 00,000 |
| Scope 2 | 251,390 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Antengene is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
